The Army’s Quick Cure
Research for a Covid-19 drug by Airlangga University sparked a polemic. Aside from its effectiveness, its adherence to clinical trials protocol is also questioned. The ball is now in the Indonesia Food and Drug Authority’s court.
Abdul Manan
August 24, 2020
THE Rector of Airlangga University (Unair), Mohammad Nasih, hurried to the E Building in the Indonesian Army Headquarters in Jalan Veteran, Central Jakarta, on Saturday, August 15. He was there to deliver the phase III clinical trial result of a Covid-19 drug to the Army—which is sponsoring the research, alongside the State Intelligence Agency (BIN). “Of course, since this will be a new drug, it is expected to be the first Covid-19 cu
...